Skoči na glavni sadržaj

Sažetak sa skupa

https://doi.org/10.15836/ccar2024.405

Cardiac stereotactic body radiation therapy in advanced heart failure patients with recurrent ventricular tachycardia – a case series

Vedran Pašara orcid id orcid.org/0000-0002-6587-2315 ; University Hospital Centre Zagreb, Zagreb, Croatia
Ivan Prepolec ; University Hospital Centre Zagreb, Zagreb, Croatia
Andrija Nekić orcid id orcid.org/0000-0003-1214-8646 ; University Hospital Centre Zagreb, Zagreb, Croatia
Hrvoje Šobat orcid id orcid.org/0000-0001-7677-4297 ; Special Hospital Radiochirurgia Zagreb, Sveta Nedelja, Croatia
Dragan Schwarz orcid id orcid.org/0000-0002-4421-0865 ; Special Hospital Radiochirurgia Zagreb, Sveta Nedelja, Croatia
Davor Miličić orcid id orcid.org/0000-0001-9101-1570 ; University Hospital Centre Zagreb, Zagreb, Croatia
Vedran Velagić orcid id orcid.org/0000-0001-5425-5840 ; University Hospital Centre Zagreb, Zagreb, Croatia


Puni tekst: engleski pdf 153 Kb

str. 405-405

preuzimanja: 115

citiraj

Preuzmi JATS datoteku


Sažetak

Ključne riječi

stereotactic body radiotherapy; ventricular tachycardia; advanced heart failure

Hrčak ID:

327838

URI

https://hrcak.srce.hr/327838

Datum izdavanja:

13.12.2024.

Posjeta: 337 *



Introduction: Cardiac stereotactic body radiotherapy (SBRT) is a treatment option for patients with refractory ventricular tachycardia (VT) despite optimal medical therapy and one or more failed catheter ablation procedures. (1) Several studies have reported that SBRT is associated with reduced VT burden and implantable cardioverter defibrillator (ICD) therapies. (2) This study aimed to assess the clinical outcomes of cardiac SBRT for VT in our institution.

Patients and Methods: The target substrate for radioablation was determined by combining a preprocedural cardiac computed tomography (CT) scan and 3D cardiac modeling software merged with a real-time CT scan for simulation. All patients were treated with a single 25 Gy fraction using respiratory motion mitigation strategies. We analyzed the outcome of death, the incidence of recurrent VT, and possible side effects of irradiation.

Results: Three men aged 34, 61, and 66 years with advanced heart failure as a consequence of ischemic heart disease were referred for cardiac SBRT due to VT and ICD therapy recurrence despite antiarrhythmic drugs (AADs) and previously failed catheter ablations for VT. Cardiac SBRT was successfully performed in all patients. During the follow-up, all patients had VT recurrence. In two patients, it happened during a 6-week blanking period, while the third patient had VT recurrence after six months. Two patients eventually received a heart transplant, one and ten months after cardiac SBRT, respectively. The third patient underwent endocardial-epicardial catheter ablation for VT a month after receiving cardiac SBRT, but eventually died nine months post-SBRT due to advanced heart failure worsening. There were no radiotherapy-related adverse events observed during follow-up.

Conclusion: We demonstrated the feasibility and safety of cardiac SBRT in advanced heart failure patients. However, cardiac SBRT did not achieve successful mid-term arrhythmia control in our selected high-risk patients, and, therefore, efficacy aspects remain unclear. Further studies are needed to clarify this issue.

LITERATURE

1 

Ninni S, Gallot-Lavallée T, Klein C, Longère B, Brigadeau F, Potelle C, et al. Stereotactic Radioablation for Ventricular Tachycardia in the Setting of Electrical Storm. Circ Arrhythm Electrophysiol. 2022 September;15(9):e010955. https://doi.org/10.1161/CIRCEP.122.010955 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/36074658

2 

Arkles J, Markman T, Trevillian R, Yegya-Raman N, Garg L, Nazarian S, et al. One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardia. Heart Rhythm. 2024 January;21(1):18–24. https://doi.org/10.1016/j.hrthm.2023.10.005 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/37827346


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.